Resistant Hypertension: Time to Consider the Best Fifth Anti-Hypertensive Treatment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resistant Hypertension: Time to Consider the Best Fifth Anti-Hypertensive Treatment
Authors
Keywords
Resistant hypertension, Treatment, Spironolactone, Clonidine, Blood pressure
Journal
CURRENT HYPERTENSION REPORTS
Volume 20, Issue 8, Pages -
Publisher
Springer Nature
Online
2018-06-16
DOI
10.1007/s11906-018-0866-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?
- (2018) J. C. Yugar-Toledo et al. CURRENT HYPERTENSION REPORTS
- Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant HypertensionNovelty and Significance
- (2018) Eduardo M. Krieger et al. HYPERTENSION
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- (2017) Paul K. Whelton et al. HYPERTENSION
- Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
- (2017) Raymond R Townsend et al. LANCET
- Device-based Therapy for Hypertension
- (2016) Fu L. Ng et al. CURRENT HYPERTENSION REPORTS
- Spironolactone versus sympathetic renal denervation to treat true resistant hypertension
- (2016) Anna Oliveras et al. JOURNAL OF HYPERTENSION
- The Effects of Aldosterone Antagonists in Patients With Resistant Hypertension: A Meta-Analysis of Randomized and Nonrandomized Studies
- (2015) Khagendra Dahal et al. AMERICAN JOURNAL OF HYPERTENSION
- New Approaches in the Treatment of Hypertension
- (2015) S. Oparil et al. CIRCULATION RESEARCH
- Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
- (2015) Bryan Williams et al. LANCET
- Resistant Hypertension Optimal Treatment Trial: A Randomized Controlled Trial
- (2013) CLINICAL CARDIOLOGY
- Resistant hypertension and target organ damage
- (2013) Maria Lorenza Muiesan et al. HYPERTENSION RESEARCH
- Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients
- (2012) Stacie L. Daugherty et al. CIRCULATION
- Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis
- (2012) Dharam J. Kumbhani et al. EUROPEAN HEART JOURNAL
- Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008
- (2011) Brent M. Egan et al. CIRCULATION
- Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)
- (2011) Jan Václavík et al. HYPERTENSION
- Uso de espironolactona o doxazosina en pacientes con hipertensión arterial refractaria
- (2011) Enrique Rodilla et al. REVISTA ESPANOLA DE CARDIOLOGIA
- A Simplified Approach to the Treatment of Uncomplicated Hypertension
- (2009) Ross D. Feldman et al. HYPERTENSION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now